Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2018; 10(01): 017-020
DOI: 10.4103/JLP.JLP_9_17
Original Article

Pattern of bone marrow involvement in non Hodgkin’s lymphoma classified according to WHO classification: Report of a developing country Pakistan

Sadia Sultan
Department of Hematology and Blood Bank, Liaquat National Hospital and Medical College, Karachi, Pakistan
,
Naseer Baloch
Department of Anatomy, Liaquat National Medical College, Karachi, Pakistan
,
Zeeshan Ansar Ahmed
Department of Pathology and Laboratory Medicine, The Aga Khan University Hospital, Karachi, Pakistan
,
Syed Mohammed Irfan
Department of Hematology and Blood Bank, Liaquat National Hospital and Medical College, Karachi, Pakistan
,
Saira Parveen
Department of Hematology and Blood Bank, Liaquat National Hospital and Medical College, Karachi, Pakistan
› Author Affiliations Financial support and sponsorship: Nil
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

BACKGROUND: Limited information is available from developing countries in patients of non-Hodgkin's lymphoma (NHL). Hence, we reviewed the demographical profile along with bone marrow infiltration pattern in patients with NHL presented at Liaquat National Hospital and Medical College.

MATERIALS AND METHODS: In this descriptive study, adult patients with NHL were enrolled from January 2011 to December 2015.

RESULTS: One hundred and Eighty-four histopathologically confirmed cases of NHL were identified. There were 139 males and 45 females, with a male-to-female ratio of 3:1. The mean age was 48.5 ± 16.0 years with the median age of 50 years. B-symptoms were present in 80.4% of patients. Lymph node enlargement was present in 71.1% of the cases. One hundred and sixty-eight patients had B-cell lymphoma (91.3%) and 16 patients had T-cell lymphoma (8.6%). Overall 158 (85.8%) patients had aggressive lymphoma. The frequency of bone marrow infiltration in our NHL patients was found to be 31.5%. Pattern of infiltrate was diffuse (14.6%) predominantly followed by interstitial (6.5%) and paratrabecular (5.4%) types of infiltration. The least common was nodular infiltrate accounted in 9 (4.8%) patients.

CONCLUSIONS: B-cell lymphoma is more frequent than T-cell lymphoma. Younger age, aggressive lymphoma, and predominance of B-symptoms are more frequently seen. Diffuse bone marrow infiltration is more common in our set up probably because of a relatively late presentation in our patients.

Key words

Non-Hodgkin's lymphoma - Pakistan - WHO subtypes


Publication History

Received: 11 January 2017

Accepted: 30 June 2017

Article published online:
19 February 2020

© 2018.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Chakrabarti S, Sarkar S, Goswami BK, Mondal S, Roy A, Das S. Hodgkin's and Non-Hodgkin's lymphomas in an Indian Rural medical institution: Comparative clinicopathologic analysis. Asian Pac J Cancer Prev 2010;11:1605-8.
  • 2 Hazarika M, Iqbal A, Krishnatreya M, Sharma JD, Bhuyan C, Saikia BJ, et al. Adult non-Hodgkin's lymphoma patients: Experience from a tertiary care cancer centre in North East India. Asian Pac J Cancer Prev 2015;16:2879-81.
  • 3 Dehghani M, Haddadi S, Vojdani R. Signs, symptoms and complications of non-Hodgkin's lymphoma according to grade and stage in South Iran. Asian Pac J Cancer Prev 2015;16:3551-7.
  • 4 Knauf WU, Gückel F, Döhner H, Semmler W, Trümper L, Ho AD. Detection of bone marrow infiltration by non-Hodgkin's lymphoma – comparison of histological findings, analysis of gene rearrangements, and examination by magnetic resonance imaging. Klin Wochenschr 1991;69:345-50.
  • 5 Mushtaq S, Akhtar N, Jamal S, Mamoon N, Khadim T, Sarfaraz T, et al. Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms. Asian Pac J Cancer Prev 2008;9:229-32.
  • 6 Gad-el-Mawla N, Hamza MR, Abdel-Hadi S, el-Tannir O, Hussein MH, el-Haddad A, et al. Prolonged disease-free survival in pediatric non-Hodgkin's lymphoma using ifosfamide-containing combination chemotherapy. Hematol Oncol 1991;9:281-6.
  • 7 Bukhari U, Jamal S, Lateef F. Non-Hodgkin lymphoma-A study. Pak Oral Dent J 2015;35:412-5.
  • 8 Durosinmi MA, Mabayoje VO, Akinola NO. A review of histology of bone marrow trephine in malignant lymphomas. Niger J Med 2003;12:198-201.
  • 9 Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
  • 10 Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet 2012;380:848-57.
  • 11 Obafunwa JO, Akinsete I. Malignant lymphomas in Jos, Nigeria: A ten-year study. Cent Afr J Med 1992;38:17-25.
  • 12 Abrar A, Sadaqat AG. Non-Hodgkin's lymphoma in South Punjab. Retrospective analysis of 148 patients. Pak J Med Res 1989;28:223-31.
  • 13 Kim JM, Ko YH, Lee, SS, Huh J, Kang CS, Kim CW, et al. WHO classification of malignant lymphomas in Korea: Report of the third Nationwide study. Korean J Pathol 2011;45:254-60.
  • 14 Lee SJ, Suh CW, Lee SI, Kim WS, Lee WS, Kim HJ, et al. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: Nationwide Korean study. Korean J Intern Med 2014;29:352-60.
  • 15 Malik S, Ahmad S, Saleem M. Bone marrow involvement in non-Hodgkin's lymphoma. A study of 41 untreated cases. Pak Armed Forces Med J 1992;42:90-2.
  • 16 Hassan K, Ikram N, Bukhari KP, Shah SH. The pattern of bone marrow infiltration in non-Hodgkin's lymphomas. J Pak Med Assoc 1995;45:173-6.
  • 17 Jamila, Hassan K. Pattern of bone marrow infiltration in non-Hodgkin's lymphomas. J Rawal Med Coll 2008:12:66-71.
  • 18 Isikdogan A, Ayyildiz O, Buyukcelik A, Arslan A, Tiftik N, Buyukbayram H, et al. Non-Hodgkin's lymphoma in southeast Turkey: Clinicopathologic features of 490 cases. Ann Hematol 2004;83:265-9.
  • 19 Arber DA, George TI. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: Frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol 2005;29:1549-57.